0001104659-23-125434.txt : 20231212 0001104659-23-125434.hdr.sgml : 20231212 20231212173022 ACCESSION NUMBER: 0001104659-23-125434 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231208 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Steven Clive CENTRAL INDEX KEY: 0001883325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40825 FILM NUMBER: 231482194 MAIL ADDRESS: STREET 1: C/O WARBY PARKER INC. STREET 2: 233 SPRING STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Warby Parker Inc. CENTRAL INDEX KEY: 0001504776 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 800423634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 847-7215 MAIL ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: JAND, Inc. DATE OF NAME CHANGE: 20101102 4 1 tm2332712-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-12-08 0 0001504776 Warby Parker Inc. WRBY 0001883325 Miller Steven Clive C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR EAST NEW YORK NY 10013 0 1 0 0 Chief Financial Officer 1 Class A Common Stock 2023-12-08 4 M 0 18480 0 A 207064 D Class A Common Stock 2023-12-08 4 S 0 7760 10.56 D 199304 D Class A Common Stock 2023-12-11 4 S 0 21550 11.42 D 177754 D Restricted Stock Units 2023-12-08 4 M 0 1981 0 D Class A Common Stock 1981 9245 D Restricted Stock Units 2023-12-08 4 M 0 2525 0 D Class A Common Stock 2525 1684 D Restricted Stock Units 2023-12-08 4 M 0 5095 0 D Class A Common Stock 5095 33973 D Restricted Stock Units 2023-12-08 4 M 0 8879 0 D Class A Common Stock 8879 112477 D Includes 1,332 shares acquired on May 14, 2023 under the Issuer's employee stock purchase plan in an exempt transaction pursuant to Rule 16b-3(c). These share sales are required by the Issuer's equity compensation plan to cover taxes due on restricted stock units ("RSUs") that vested. These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2023. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $10.52 to $11.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock. This filing relates to the occurrence of a RSU vesting event. The RSUs will vest in 48 monthly installments beginning on January 1, 2021. The RSUs will vest in 48 monthly installments beginning on January 1, 2020. The RSUs will vest in 48 monthly installments beginning on July 1, 2021. The RSUs will vest in 48 substantially equal monthly installments beginning on February 3, 2023. /s/ Chris Utecht, Attorney-in-Fact 2023-12-12